Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $11.00 at Royal Bank Of Canada

Aveanna Healthcare (NASDAQ:AVAH) had its target price raised by equities researchers at Royal Bank Of Canada from $10.00 to $11.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has a “sector perform” rating on the stock. Royal Bank Of Canada’s price target indicates a potential upside of 17.05% from the stock’s current price.

A number of other research firms also recently issued reports on AVAH. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Monday, December 29th. Truist Financial boosted their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research note on Friday, November 7th. BMO Capital Markets started coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They set an “outperform” rating and a $11.00 price target on the stock. William Blair assumed coverage on shares of Aveanna Healthcare in a research note on Monday, December 8th. They issued an “outperform” rating for the company. Finally, UBS Group lifted their price target on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a report on Friday, November 7th. Five research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $10.88.

Aveanna Healthcare Stock Up 0.6%

Shares of NASDAQ AVAH traded up $0.06 during mid-day trading on Thursday, hitting $9.40. The company had a trading volume of 140,331 shares, compared to its average volume of 1,275,266. The company has a market capitalization of $1.96 billion, a PE ratio of 25.97 and a beta of 2.06. The business’s 50-day simple moving average is $8.80 and its 200 day simple moving average is $7.72. Aveanna Healthcare has a 1-year low of $3.67 and a 1-year high of $10.32. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.08. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The business had revenue of $621.94 million during the quarter, compared to analysts’ expectations of $578.57 million. On average, analysts predict that Aveanna Healthcare will post -0.06 earnings per share for the current year.

Insider Buying and Selling

In other news, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total transaction of $75,114,531.00. Following the completion of the sale, the insider owned 20,544,696 shares of the company’s stock, valued at approximately $184,902,264. This represents a 28.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 10,000,000 shares of Aveanna Healthcare stock in a transaction on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the completion of the transaction, the insider directly owned 386,284 shares in the company, valued at approximately $3,476,556. The trade was a 96.28% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 32,857,606 shares of company stock worth $295,491,307 over the last three months. Insiders own 7.80% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

Large investors have recently made changes to their positions in the business. Dynamic Technology Lab Private Ltd lifted its holdings in Aveanna Healthcare by 8.9% in the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock worth $126,000 after buying an additional 1,151 shares during the period. Barclays PLC lifted its position in Aveanna Healthcare by 0.8% during the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock valued at $1,591,000 after buying an additional 1,366 shares during the period. Franklin Resources Inc. lifted its position in Aveanna Healthcare by 4.5% during the 3rd quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after acquiring an additional 1,528 shares during the period. Olympiad Research LP boosted its holdings in Aveanna Healthcare by 7.5% in the third quarter. Olympiad Research LP now owns 31,621 shares of the company’s stock worth $280,000 after acquiring an additional 2,200 shares in the last quarter. Finally, SG Americas Securities LLC grew its position in Aveanna Healthcare by 15.2% during the 4th quarter. SG Americas Securities LLC now owns 19,906 shares of the company’s stock valued at $163,000 after purchasing an additional 2,624 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.